June 25, 2012
In a major win for Teva Pharmaceutical Industries Ltd., a judge has ruled that Mylan Pharmaceuticals Inc. and Sandoz Inc. infringed the Israeli drugmaker's patents for Copaxone in making generic versions of the multiple sclerosis drug.
September 07, 2011
An attorney for Mylan Pharmaceuticals Inc. told a New York federal judge Wednesday that its generic version of Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone doesn't infringe several Teva patents.